Merck teams up with the Medicines for Malaria Venture

Apr 2009

Merck & Co. has partnered with the Medicines for Malaria Venture (MMV) in a deal that could bring both entities access to a new malaria drug.

Alliance
- Includes Royalty or Profit Split Information
- R+D and Marketing-Licensing

Already a Strategic Transactions subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Merck teams up with the Medicines for Malaria Venture

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice